Dry cough medicine for adults (Mixture conta tussis for adults siccum)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspPowder for solution for oral administration
Composition:

Per one packing:

Active components:

Thermopsis extract is dry with the amount of alkaloids in terms of thermopsin and absolutely dry substance 1.0%

0.045 g

Licorice extract dry

with the content of glycyrrhizic acid in terms of the monoammonium salt of glycyrrhizic acid hydrate and absolutely dry matter 17.0%

0.150 g

Sodium bicarbonate

0.300 grams

Excipients:

Sugar (sucrose)

0.7500 g

Sodium benzoate

0.3000 g

Ammonium chloride

0.1500 g

Anise oil

0.0037 g

Powder weight in packing

1.7 g
Description:

Inhomogeneous powder mixture from grayish brown to brownish-gray with a pinkish hue of color with lighter and darker inclusions, with the smell of anise oil. During storage, it is allowed to clump. The aqueous solution of the preparation (1:10) should be brown.

Pharmacotherapeutic group:Expectorant of plant origin
ATX: & nbsp
  • Combination of expectorants
    • Pharmacodynamics:

    Combined drug.

    It has an expectorant, antitussive and anti-inflammatory effect, it helps to remove mucus from the respiratory tract. Thermopsis dry extract enhances the secretion of the bronchial glands; sodium hydrogen carbonate shifts the pH of bronchial mucus to the alkaline side, reduces the viscosity of sputum; licorice extract dry and aniseed oil have anti-inflammatory and antispasmodic effect; sodium benzoate and ammonium chloride have an expectorant effect.

    Pharmacokinetics:

    No data available.

    Indications:

    Diseases of the respiratory tract, accompanied by a cough with hard-to-separate sputum (tracheitis, bronchitis, bronchopneumonia).

    Contraindications:

    Hypersensitivity to the drug components, acute glomerulonephritis, acute pyelonephritis, pregnancy and the period of breastfeeding, age to 18 years. Congenital intolerance of fructose, glucose-galactose malabsorption, deficiency of sugar / isomaltase.

    If you have any of these diseases, consult a doctor before taking the drug.

    Carefully:

    Patients with diabetes and people on a diet with a low carbohydrate content and low sodium content.

    If you have any of these diseases, consult a doctor before taking the drug.

    Dosing and Administration:

    Inside, in the form of a solution 3-4 times a day after meals.

    To prepare the solution, the contents of the packet (1.7 g) are dissolved in 1 tablespoon (15 ml) of cooled boiled water.

    The course of treatment is from 14 to 20 days. Conducting repeated courses of treatment is possible after consultation with a doctor.

    Side effects:

    There may be allergic reactions, nausea, vomiting, diarrhea; can have irritating effect on the mucous membrane of the stomach. In these cases, the drug should be discontinued.

    If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, inform the doctor about it.

    Overdose:

    To date, no cases of overdose have been observed.

    Interaction:

    It is not recommended to apply simultaneously with antitussive drugs, as well as with drugs that reduce the formation of sputum.

    Special instructions:

    Patients with diabetes should take into account that one package contains about 0.75 g of carbohydrates (0.0625 XE).

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities,requiring increased concentration of attention and speed of psychomotor reactions.

    Form release / dosage:Powder for solution for oral administration.
    Packaging:

    By 1.7 grams in packages heat-sealable from paper packaging with polyethylene coating, or from paper laminated, or from composite material.

    Packages, together with an equal number of instructions for use, are placed in a box or in a cardboard box.

    Storage conditions:

    In a dry place, at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-002164
    Date of registration:31.07.2013
    Expiration Date:31.07.2018
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspVIFITEH, CJSCVIFITEH, CJSC
    Information update date: & nbsp08.06.2018
    Illustrated instructions
      Instructions
      Up